Sarah Condella - Jan 9, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, Human Resources
Signature
/s/ Sarah Condella by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Jan 9, 2023
Transactions value $
-$44,450
Form type
4
Date filed
1/11/2023, 03:03 PM
Previous filing
Mar 2, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $15.6K +328 +0.38% $47.41 86.1K May 2, 2022 Direct F1
transaction EXAS Common Stock Sale -$60K -1K -1.16% $60.00 85.1K Jan 9, 2023 Direct F2, F3
holding EXAS Common Stock 5.16K Jan 9, 2023 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased through Employee Stock Purchase Plan.
F2 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in February 2022.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 90,245 shares, Ms. Condella also holds, in the aggregate, an additional 80,895 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.